Patents by Inventor Priyank Sharma

Priyank Sharma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID ORAL DOSAGE FORMS OF ESLICARBAZEPINE
    Publication number: 20210161823
    Abstract: The present invention relates to high drug load pharmaceutical compositions comprising eslicarbazepine or its pharmaceutically acceptable salts, esters, solvates, polymorphs, enantiomers or mixtures thereof. The present invention also relates to a process for preparing high drug load solid oral pharmaceutical composition comprising eslicarbazepine acetate and at least one pharmaceutically acceptable excipient. The prior art highlights various technical challenges for formulation development of eslicarbazepine acetate at lab as well as at industrial scale and offer restrictive and complex approach for resolution of technical challenges. Compositions of eslicarbazepine acetate prepared as per present invention, wherein disintegrant and/or binder is present in either intra-granular part or in extra-granular part of the composition exhibited desirable technical attributes like comparable dissolution and bioequivalence against reference listed drug.
    Type: Application
    Filed: February 5, 2021
    Publication date: June 3, 2021
    Inventors: Ravikumar Nithiyanandam, Ganesh Vinayak Gat, Dinesh Kumar, Kamal S. Mehta, Premchand Dalichandji Nakhat, Vivek Jain, Priyank Sharma, Baibhav Joshi
  • Solid oral dosage forms of eslicarbazepine
    Patent number: 10918604
    Abstract: The present invention relates to high drug load pharmaceutical compositions comprising Eslicarbazepine or its pharmaceutically acceptable salts, esters, solvates, polymorphs, enantiomers or mixtures thereof. The present invention also relates to a process for preparing high drug load solid oral pharmaceutical composition comprising Eslicarbazepine acetate and at least one pharmaceutically acceptable excipient. The prior art highlights various technical challenges for formulation development of Eslicarbazepine acetate at lab as well as at industrial scale and offer restrictive and complex approach for resolution of technical challenges. Compositions of Eslicarbazepine acetate prepared as per present invention, wherein disintegrant and/or binder is present in either intra-granular part or in extra-granular part of the composition exhibited desirable technical attributes like comparable dissolution and bioequivalence against reference listed drug.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: February 16, 2021
    Inventors: Ravikumar Nithiyanandam, Ganesh Vinayak Gat, Dinesh Kumar, Kamal S. Mehta, Premchand Dalichandji Nakhat, Vivek Jain, Priyank Sharma, Baibhav Joshi
  • SOLID ORAL DOSAGE FORMS OF ESLICARBAZEPINE
    Publication number: 20180280307
    Abstract: The present invention relates to high drug load pharmaceutical compositions comprising Eslicarbazepine or its pharmaceutically acceptable salts, esters, solvates, polymorphs, enantiomers or mixtures thereof. The present invention also relates to a process for preparing high drug load solid oral pharmaceutical composition comprising Eslicarbazepine acetate and at least one pharmaceutically acceptable excipient. The prior art highlights various technical challenges for formulation development of Eslicarbazepine acetate at lab as well as at industrial scale and offer restrictive and complex approach for resolution of technical challenges. Compositions of Eslicarbazepine acetate prepared as per present invention, wherein disintegrant and/or binder is present in either intra-granular part or in extra-granular part of the composition exhibited desirable technical attributes like comparable dissolution and bioequivalence against reference listed drug.
    Type: Application
    Filed: December 16, 2016
    Publication date: October 4, 2018
    Inventors: Ravikumar NITHIYANANDAM, Ganesh Vinayak GAT, Dinesh KUMAR, Kamal S. MEHTA, Premchand Dalichandji NAKHAT, Vivek JAIN, Priyank SHARMA, Baibhav JOSHI
  • Method and system for quantitative renal assessment
    Patent number: 9173590
    Abstract: Method and system embodiments of the present invention employ computational analysis tools running on one or more computer systems to quantitatively analyze MRI data from patients in order to both assess various functional parameters and characteristics of a patient's kidney, as well as to provide an electronic display device interconnected with the one or more computer systems, and accessible visualization of the quantitative assessment to facilitate diagnosis of various types of kidney abnormalities and pathologies.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: November 3, 2015
    Assignee: Children's Hospital Los Angeles
    Inventors: Rex Moats, Yang Tang, Priyank Sharma, Hollie Jackson
  • METHOD AND SYSTEM FOR QUANTITATIVE RENAL ASSESSMENT
    Publication number: 20130084246
    Abstract: Method and system embodiments of the present invention employ computational analysis tools running on one or more computer systems to quantitatively analyze MRI data from patients in order to both assess various functional parameters and characteristics of a patient's kidney, as well as to provide an electronic display device interconnected with the one or more computer systems, and accessible visualization of the quantitative assessment to facilitate diagnosis of various types of kidney abnormalities and pathologies.
    Type: Application
    Filed: May 17, 2011
    Publication date: April 4, 2013
    Applicant: CHILDREN'S HOSPITAL LOS ANGELES
    Inventors: Rex Moats, Yang Tang, Priyank Sharma, Hollie Jackson